Below is Validea's guru fundamental report for MCKESSON CORP (MCK). Of the 22 guru strategies we follow, MCK rates highest using our Multi-Factor Investor model based on the published strategy of Pim ...
McKesson Corporation is transforming from a traditional distributor to a tech-enabled healthcare services leader, focusing on high-margin specialty and digital solutions. Recent acquisitions (PRISM ...
McKesson Corporation is rated 'Buy' due to its transformation into a higher-growth, higher-margin healthcare services platform focused on Oncology & Multispecialty and Prescription Technology ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
PFRM3.SA Profarma Distribuidora de Produtos Farmacêuticos S.A.
SHTDY Sinopharm Group Co. Ltd.
After hours: 8 October at 19:52:01 GMT-4 Chart does not reflect overnight price.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback